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Purpose: To investigate the association and ethnic heterogeneity of lysyl oxidase-like 1 (LOXL1) single nucleotide
polymorphisms (SNPs) with exfoliation syndrome (XFS)/exfoliation glaucoma (XFG) and other types of glaucoma.
Methods: We performed meta-analysis and ethnicity-based subgroup analyses according to published studies. Allele and
genotype frequencies of SNPs rs1048661, rs2165241, and rs3825942 were extracted for analysis in Reviewer Manager:
(1) comparison of the allelic distributions between XFS and XFG, (2) allelic association of LOXL1 SNPs with XFS/XFG,
(3) associations in homozygote, heterozygote, and dominant and recessive models, and (4) allelic association with primary
open angle glaucoma (POAG).
Results: In total 24 reported articles were retrieved, including Caucasian, African, Japanese, Indian, and Chinese
populations. There was no significant difference in the distributions of rs1048661, rs2165241, and rs3825942 between
XFS and XFG. The G allele of rs3825942 was the common at-risk allele for XFS/XFG in all populations with a total odds
ratio (OR) of 10.89. The total homozygote OR of rs3825942 was 9.06 for XFS/XFG combined, but the total heterozygote
OR was not significant. We also found that in the recessive model, the total OR was 14.70. There was no association of
the three SNPs with POAG.
Conclusions: The association of rs3825942, but not rs2165241 or rs1048661, with XFS/XFG is consistent in different
ethnic populations in the recessive model. LOXL1 is not associated with POAG in all study populations.
Glaucoma is one of the leading causes of irreversible
blindness worldwide. It is a group of heterogeneous diseases
characterized by progressive loss of retinal ganglion cells and
degenerative  optic  neuropathy  with  or  without  elevated
intraocular  pressure  (IOP)  [1].  Open  angle  glaucoma  is  a
major form of glaucoma and can be classified into primary
open  angle  glaucoma  (POAG)  and  secondary  open  angle
glaucoma. Exfoliation glaucoma (XFG) is the most common
form of secondary open angle glaucoma and is caused by
obstruction of extracellular material in the anterior chamber
angle in exfoliation syndrome (XFS), which is an age-related
disease characterized by deposits of extracellular material in
the  anterior  segment,  including  the  cornea,  lens,  iris,  and
anterior chamber [2]. The prevalence of XFS varies widely
across  different  ethnic  populations.  In  people  aged  60  or
above, the prevalence of XFS is 0.4% in Hong Kong Chinese
[3], 0.7% in Singapore Chinese [4], 4.4% in Japanese [5], and
10%–20% in the Caucasian population [6].
The etiology and pathogenesis of glaucoma are complex
and  involve  multiple  genetic  and  environmental  factors.
Myocilin  (MYOC)  is  a  causative  gene  for  POAG  and
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cytochrome P450, 1B1 (CYP1B1) for congenital glaucoma
[7,8]. Mutations in optineurin (OPTN) and WD repeat domain
36 (WDR36) do not directly lead to POAG but increase the
risk [9,10]. As for XFS and XFG, significant association with
three  single  nucleotide  polymorphisms  (SNPs),
rs1048661,rs2165241, and rs3825942, in the Lysyl oxidase-
like 1 (LOXL1) gene was first discovered in 2007 in Icelandic
and Swedish populations by a genome-wide association study
[11]. SNP rs2165241 was marginally (p=0.04) associated with
POAG in the Icelandic but not in the Swedish population,
while rs3825942 and rs1048661 were not associated with
POAG in either population [11].
Since then the association of LOXL1 SNPs with XFS/
XFG has been reported in Caucasian populations in the USA
[12-16], Australia [17], Austria [18], Germany [19,20], Italy
[20], and Finland [21] and in other ethnic groups, including
Japanese [22-27], Indian [28], and Chinese [29,30]. LOXL1
SNPs in POAG have also been studied in Caucasian [14,21,
31],  Japanese  [22,24,27],  Chinese  [32],  Indian  [33],  and
African populations [31]. Other types of glaucoma, such as
normal tension glaucoma and pigmentary glaucoma, have
been investigated in India [33], Japan [27], Germany [19], and
the USA [34]. Despite the large amount of information, the
overall association of SNPs and the discrepancies between
individual cohorts or subgroups remain to be characterized.
Meta-analysis is a very useful statistical tool not only to
summarize data from individual studies concerning a specific
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%research  question  but  also  to  identify  and  analyze  the
consistency  and  discrepancies  of  individual  studies  or
population subgroups. The prevalence of XFS/XFG varies
widely  among  different  ethnic  populations  mainly  due  to
variations  in  genetic  background.  Therefore,  to  ascertain
effects due to ethnic differences, meta-analysis of the genetic
association  of  LOXL1  SNPs  with  glaucoma  could  be
performed based on subgrouping by ethnicity. In LOXL1,
three SNPs (rs1048661, rs2165241, and rs3825942) were first
found associated with XFS/XFG in Icelandic and Swedish
populations. They appeared in most of the reported studies,
despite some inconsistencies in their presence [16,24,29,31].
Several other SNPs at LOXL1 (rs12437465,rs2304719, and
rs3522)  have  also  been  reported  [13,17,31],  but  their
associations were due to intermarker linkage disequilibrium
(LD)  and  limited  functional  studies  of  these  SNPs  were
reported, so they were not included in this meta-analysis. In
this study, we perform a subgroup based meta-analysis using
all of the reported studies on the association of LOXL1 SNPs
(rs1048661, rs2165241, and rs3825942) with XFS, XFG, and
POAG.
METHODS
An  internet-based  literature  search  was  conducted  on
PubMed and Embase, using the search strategy (“LOXL1”
OR “LOXL” OR “Lysyl oxidase-like”) AND (“glaucoma”
OR “exfoliation” OR “pseudoexfoliation”). The cut-off date
was December 12, 2009. In total 41 articles were obtained
from PubMed and 38 from Embase. Articles meeting the
following criteria were included for further data analysis: (1)
case-control  study,  cohort  study,  or  population-based
Figure  1.  Meta-analysis  of  the  distribution  of  single  nucleotide
polymorphism  (SNP)  rs1048661  between  exfoliation  syndrome
(XFS) and exfoliation glaucoma (XFG). Squares indicate study-
specific odds ratio   (OR); the size of the box is proportional to the
weight of the study; horizontal lines indicate 95% confidence interval
(CI); diamond indicates summary OR with its corresponding 95%
CI.  Meta-analysis  indicated  there  is  no  statistical  difference  of
distribution of the SNP rs1048661 G and T allele between XFS and
XFG.
epidemiological survey; (2) reports on the association of three
SNPs  in  LOXL1,  i.e.,  rs1048661,  rs2165241,  and/or
rs3825942, with XFS, XFG, POAG, or/and other types of
glaucoma; (3) studies with reported and accessible sample
size,  allele,  and/or  genotype  frequencies/counts  in  both
patients and controls; and (4) original research articles, not
reviews or comments. Repetitive publications, which were
Figure  2.  Meta-analysis  of  the  distribution  of  single  nucleotide
polymorphism  (SNP)  rs2165241  between  exfoliation  syndrome
(XFS) and exfoliation glaucoma (XFG). Squares indicate study-
specific odds ration (OR); the size of the box is proportional to the
weight of the study; horizontal lines indicate 95% confidence interval
(CI); diamond indicates summary OR with its corresponding 95%
CI.  Meta-analysis  indicated  there  is  no  statistical  difference  of
distribution of the SNP rs2165241 T and C allele between XFS and
XFG.
Figure  3.  Meta-analysis  of  the  distribution  of  single  nucleotide
polymorphism  (SNP)  rs3825942  between  exfoliation  syndrome
(XFS) and exfoliation glaucoma (XFG). Squares indicate study-
specific risk difference (RD);  the size of the box is proportional to
the  weight  of  the  study;  horizontal  lines  indicate  95%  confidence
interval  (CI);   diamond   indicates  summary  RD  with  its  cor-
responding 95%  CI.  Meta-analysis  indicated  there  is  no  statis
tical difference of distribution of the SNP rs3825942 G and A allele
between XFS and XFG.
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169ruled out through tracking references, were incorporated as
the latest reports. If several different cohorts were reported in
the same article, they were treated as independent studies.
The  retrieved  abstracts  and  full  texts  were  separately
reviewed by two investigators (H.Y.C. and W.F.G.) who also
independently  performed  data  extraction  and  quality
evaluation. A third reviewer (L.J.C.) would participate in the
review if there was disagreement in the retrieved information.
Total consensus of the three reviewers needed to be obtained
on all retrieved data. The ethnicity, sample size, age, sex,
allele, and/or genotype frequency/counts in both patients and
controls were recorded. For studies with no direct data of
genotype  or  allele  counts,  we  calculated  the  frequency
according to the reported data, rounding to the closest integer.
The  allele  counting  was  also  calculated  from  genotype
counting when needed.
The  Review  Manager  (version  5.0.18;  The  Cochrane
Collaboration,  Copenhagen,  Denmark  and  SPSS  software
(ver. 16.0; SPSS Inc., Chicago, IL) were used to perform the
meta-analysis: (1) The Hardy–Weinberg equilibrium (HWE)
Figure  4.  Meta-analysis  of  the  association  of  single  nucleotide
polymorphism  (SNP)  rs1048661  with  a  combined  group  of
exfoliation  syndrome  (XFS)  and  exfoliation  glaucoma  (XFG).
Squares indicate study-specific odds ratio   (OR); the size of the box
is proportional to the weight of the study; horizontal lines indicate
95% confidence interval (CI); diamond indicates summary OR with
its corresponding 95% CI. Subgroup meta-analysis indicated that the
ORs of SNP  rs1048661 G allele are reversed in Caucasian and
Japanese.
of each SNP in the control group of each study was examined
by using χ2 analysis; (2) meta-analysis of the LOXL1 SNPs
rs1048661,  rs2165241,  and  rs3825942  was  performed  to
compare the allelic distributions between XFS and XFG; (3)
if there were no statistical differences in allelic distributions
between XFS and XFG, these two groups were combined.
Meta-analyses  of  the  allelic  associations  of  rs1048661,
rs2165241, and rs3825942 with overall XFS and XFG were
performed; (4) if positive results were obtained from allelic
association  analysis,  genotypic  association  analyses  were
performed  using  different  genetic  models,  including
multiplicative models estimating the homozygous odds ratio
(OR) and heterozygous OR as well as the dominant model and
recessive model; and (5) the allele association of rs1048661,
rs2165241, and rs3825942 with POAG was analyzed. All the
meta-analyses were performed in subgroupings by ethnicity.
In all of the meta-analyses, the ORs were estimated by the
fixed or random model according to the heterogeneity test.
When the heterogeneity test α was <0.1, a random model was
applied, and when the heterogeneity test α was >0.1, a fixed
model  was  applied.  Sensitivity  tests  were  performed,  but
studies  with  counting  data  that  were  computed  from
frequencies data were excluded.
RESULTS
There were 20 articles reporting the association of LOXL1
SNPs with XFS/XFG in a total of 3,068 cases and 20,363
Figure  5.  Meta-analysis  of  the  association  of  single  nucleotide
polymorphism  (SNP)  rs2165241  with  a  combined  group  of
exfoliation  syndrome  (XFS)  and  exfoliation  glaucoma  (XFG).
Squares indicate study-specific odds ratio   (OR); the size of the box
is proportional to the weight of the study; horizontal lines indicate
95% confidence interval (CI); diamond indicates summary OR with
its corresponding 95% CI. Subgroup meta-analysis indicated that the
ORs  of  SNP  rs2165241  T  allele  are  reversed  in  Caucasian  and
Japanese.
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170controls  from  22  study  cohorts  (Table  1).  Nine  articles
investigated the association between LOXL1 SNPs and POAG
in a total of 2,223 POAG patients and 16,664 controls from
13 cohorts (Table 2). The HWE of all three SNPs was tested
in the control groups of all cohorts. No deviation from the
HWE was identified.
There was no significant difference in allele frequencies
between XFS and XFG for rs1048661 and rs2165241 in any
cohort. The overall OR for the two SNPs was 1.15 (95%
confidence interval [CI] 0.95–1.39, p=0.15, Figure 1) and 1.15
(95% CI 0.97–1.37, p=0.10, Figure 2), respectively. The OR
due to rs3825942 could not be estimated in four out of the 11
cohorts due to 100% G allele frequencies occurring in both
the XFS and XFG groups. Therefore, we calculated the risk
difference instead of the OR. The risk difference between XFS
and XFG was 0.01 (95% CI −0.00–0.02, p=0.20, Figure 3),
and  showed  no  statistically  significant  difference  in  the
distributional profiles of the three SNPs between XFS and
XFG.  We  thus  combined  the  XFS  and  XFG  groups  in
subsequent analyses.
Figure  6.  Meta-analysis  of  the  association  of  single  nucleotide
polymorphism  (SNP)  rs3825942  with  a  combined  group  of
exfoliation  syndrome  (XFS)  and  exfoliation  glaucoma  (XFG).
Squares indicate study-specific odds ratio   (OR); the size of the box
is proportional to the weight of the study; horizontal lines indicate
95% confidence interval (CI); diamond indicates summary OR with
its corresponding 95% CI. Subgroup meta-analysis indicated that the
ORs  SNP  rs3825942  G  allele  is  consistent  in  Caucasian  and
Japanese.
Moreover, the association profiles of LOXL1 SNPs were
examined by comparing the patients with XFS or XFG versus
control subjects in different populations. The study cohorts
were from four major ethnic groups: Caucasian, Japanese,
Chinese, and Indian. In most individual studies, significant
allelic  association  was  found  between  XFS/XFG  and  the
LOXL1  SNPs  rs1048661,  rs2165241,  and  rs3825942,
regardless of ethnicity. In the association of rs3825942 with
XFS/XFG,  the  ORs  of  the  G  allele  in  every  study  was
significantly greater than 1 and the ORs lay on the same side
of  the  y-axis.  The  OR  was  9.30  (95%  CI  5.70–15.16,
p<0.00001)  in  Caucasian,  18.72  (95%  CI  10.07–34.79,
p<0.00001) in Japanese, 14.23 (95% CI 2.78–72.79, p=0.001)
in Chinese, and 4.17 (95% CI 7.04–16.55, p=0.0004) in Indian
populations. The overall OR was 10.89 (95% CI 7.20–16.45,
p<0.00001)  for  the  four  ethnic  populations  (Figure  6).
Notably, however, the ORs of rs2165241 in Caucasian and
Japanese populations were reversed. OR for the T allele was
3.39  (95%  CI  3.07–3.74,  p<0.00001)  in  Caucasian
populations, suggesting that the T allele was the at-risk allele.
The  OR  for  the  T  allele  was  0.13  (95%  CI  0.06–0.32,
p<0.00001) in Japanese populations, indicating that the T
Figure  7.  Meta-analysis  of  the  association of single nucleotide
polymorphism  (SNP)  rs3825942  with  a  combined  group  of
exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in
additive   models.     Squares   indicate   study-specific   odds    ratio
(OR); the size of the box is proportional to the weight of the study;
horizontal  lines  indicate  95%  confidence  interval  (CI);  diamond
indicates summary OR with its corresponding 95% CI. Synthesized
homozygous OR (GG versus AA) of SNP rs3825942 was 9.06 for
XFS/XFG.
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171allele was a protective allele (Figure 5). Such discrepancy was
also observed in rs1048661, with OR for the G allele being
2.35 (95% CI 2.12–2.60, p<0.00001) in Caucasian, and 0.03
(95% CI 0.01–0.06, p<0.00001) in Japanese populations but
not significant in Chinese and Indian populations (Figure 4).
Sensitivity tests were subsequently performed. Cohorts whose
allele counting data were calculated from the frequencies data,
Challa’s Duke (US) cohort [13] and Hewitt’s Austrian cohort
[17], were removed. The OR for the rs3825942 G allele was
9.30 and 12.40 in Caucasians before and after removing the
two cohorts, respectively. The OR for the rs1048661 G allele
was 2.35 and 2.41 in Caucasians before and after removing
the two cohorts, respectively. The OR for the rs2165241 T
allele  was  3.39  and  3.47  in  Caucasians  before  and  after
removing the two cohorts, respectively.
Since the associations of rs1048661 and rs2165241 are
inconsistently  reported  between  Caucasian  and  Japanese
populations,  we  performed  genotype  association  analysis
using different hereditary models only for rs3825942. When
using a multiplicative/additive model, the total OR for the
Figure  8.  Meta-analysis of the  association of  single  nucleotide
polymorphism  (SNP)  rs3825942  with  a  combined  group  of
exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in
additive    models.    Squares    indicate    study-specific    odds    ratio
(OR); the size of the box is proportional to the weight of the study;
horizontal  lines  indicate  95%  confidence  interval  (CI);  diamond
indicates  summary  OR  with  its  corresponding  95%  CI.  Meta-
analysis indicated that the heterozygote genotype (GA) does have
higher susceptibility to XFS/XFG compared to AA genotype. C:
Synthesized OR of SNP rs3825942 was 7.05 for XFS/XFG with
dominant model (GG+GA versus AA).
homozygous at-risk genotype (GG versus AA) was 9.06 (95%
CI 5.16–15.92, p<0.00001, Figure 7), whereas the total OR
for  the  heterozygous  genotype  (GA  versus  AA)  was  not
significantly different from 1 (total OR=1.39, 95% CI 0.73–
2.62, p=0.31, Figure 8). On the other hand, the total OR was
7.05 (95% CI 4.03–12.34, p<0.00001, Figure 9) under the
dominant model and 14.70 (95% CI 8.97–24.20, p<0.00001,
Figure 10) under a recessive model. By subgroup-based meta-
analysis, the ORs in different ethnic groups were comparable
as the 95% CIs partially overlapped.
There  was  no  single  article  reporting  a  significant
difference  in  allele  distributions  of  rs1048661  and
rs3825942 between POAG patients and control subjects. Our
meta-analysis  also  identified  no  significant  association
between SNP rs1048661 or rs3825942 and POAG in any
subgroup or the entire study populations. The overall OR was
0.93  (95%  CI  0.84–1.03,  p=0.16)  for  the  G  allele  of
rs1048661 (Figure 11) and 1.06 (95% CI 0.94–1.19, p=0.34)
for the G allele of rs3825942 (Figure 13). By contrast, two out
of the 12 cohorts reported significant association between
rs2165241 and POAG in Caucasian and Japanese populations.
However,  their  ORs  were  in  opposite  directions,  and  the
Figure  9.  Meta-analysis of  the association of  single  nucleotide
polymorphism  (SNP)  rs3825942  with  a  combined  group  of
exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in
dominant   models.    Squares   indicate    study-specific   odds    ratio
(OR); the size of the box is proportional to the weight of the study;
horizontal  lines  indicate  95%  confidence  interval  (CI);  diamond
indicates summary OR with its corresponding 95% CI. Synthesized
OR of SNP rs3825942 was 7.05 for XFS/XFG with dominant model
(GG+GA versus AA).
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172overall OR of the 12 studies was 0.95 (95% CI 0.82–1.10,
p=0.50) for the T allele of rs2165241 (Figure 12). Sensitivity
tests were performed in that the cohorts whose allele counting
data were calculated from frequency data, Liu’s Caucasian
and  African  cohorts  [31]  and  Chakrabarti’s  Indian  cohort
[33], were removed; however, the results were similar. None
of the overall ORs were significantly different from 1 without
the  two  cohorts.  Since  there  was  no  significant  allelic
association between the three SNPs and POAG, no further
meta-analysis (e.g., genotypic association) was performed.
Apart from XFS/XFG and POAG, there was also one
study reporting the LOXL1 SNPs in primary angle closure
glaucoma (PACG), two in normal tension glaucoma (NTG),
and  two  in  pigment  dispersion  syndrome  and  pigmentary
glaucoma.  However,  none  of  these  studies  identified  a
significant association between the LOXL1 SNPs and these
subtypes  of  glaucoma  (Table  3).  In  our  meta-analysis  to
investigate the association of LOXL1 SNPs with NTG and PG,
no statistical significant association was found (all p>0.05).
DISCUSSION
Exfoliation glaucoma (XFG), a consequence of exfoliation
syndrome (XFS), is the most common form of secondary open
Figure  10.  Meta-analysis of the association of  single  nucleotide
polymorphism  (SNP)  rs3825942  with  a  combined  group  of
exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in
recessive  models.     Squares    indicate    study-specific   odds    ratio
(OR); the size of the box is proportional to the weight of the study;
horizontal  lines  indicate  95%  confidence  interval  (CI);  diamond
indicates summary OR with its corresponding 95% CI. Synthesized
OR of SNP rs3825942 was 14.70 for XFS/XFG with recessive model
(GG versus AA+GA).
angle  glaucoma.  Approximately  25%  patients  with  XFS
present with increased IOP, and one-third have developed
glaucoma [19]. To date, association of SNPs in the LOXL1
gene with XFS and/or XFG has been shown across different
populations;  however,  there  were  several  different
phenotypes  in  these  studies.  Thus,  it  is  necessary  to  test
whether XFS and XFG are of genetic homogeneity. In the first
part of this present meta-analysis, the distribution profiles of
the LOXL1 SNPs between XFS and XFG were evaluated. By
reviewing  all  the  reported  association  profiles  with  meta-
analysis, no statistical difference in any population group or
overall study subjects was identified for any of the three SNPs
(rs1048661, rs2165241, and rs3825942). All the p values were
>0.05.
Since LOXL1 SNPs are not heterogenic in XFS and XFG,
we  combined  these  two  phenotypes  in  our  analysis.  Our
results also suggested that the LOXL1 gene may contribute to
disease  onset  of  the  exfoliation  disease  rather  than  just
increased IOP. However, the current meta-analysis cannot
prove this hypothesis because the data are from retrospective
case-control studies. Further prospective longitudinal studies
are warranted.
In most reported studies on LOXL1 and XFS/XFG, the
three  SNPs  (rs1048661,  rs2165241,  and  rs3825942)  have
been investigated together [11-23,25-28]. They are in strong
LD among different populations. The haplotype defined by
Figure  11.  Meta-analysis  of  the  association  of  single  nucleotide
polymorphism (SNP) rs1048661 with primary open angle glaucoma
(POAG). Squares indicate study-specific  odds ratio  (OR); the size
of the box is proportional to the weight of the study; horizontal lines
indicate 95% confidence interval (CI); diamond indicates summary
OR with its corresponding 95% CI. Meta-analysis indicated there is
no statistical significant association of SNP rs1048661 with POAG.
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173Figure  12.  Meta-analysis  of  the  association  of  single  nucleotide
polymorphism (SNP) rs2165241 with primary open angle glaucoma
(POAG). Squares indicate study-specific odds  ratio  (OR); the size
of the box is proportional to the weight of the study; horizontal lines
indicate 95% confidence interval (CI); diamond indicates summary
OR with its corresponding 95% CI. Meta-analysis indicated there is
no statistical significant association of SNP rs2165241 with POAG.
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174these SNPs was also significantly associated with the disease
[11,13,20,26,28]. So far, however, there is no consolidated
evidence to show which SNP plays a more major role in the
molecular pathogenesis of XFS/XFG. On the other hand, the
allelic and genotypic distributions of the three SNPs were
found to be drastically different among different populations
[11-23,25-28].  Genetic  diversity  occurs  across  different
ethnicities [35,36]. Therefore, we resolved to find out which
SNP plays a role across different populations. In the first part
of our meta-analysis, we identified genetic homogeneity of
the LOXL1 SNPs between XFS and XFG. Therefore, the two
disease groups were combined in the second part of the meta-
analysis of genetic association in subpopulations. We found
that the distribution was similar within each individual ethnic
group  for  all  three  SNPs,  rs1048661,  rs2165241, and
rs3825942. However, the allelic distributions of Japanese and
Caucasian  populations  are  reversed  for  rs1048661  and
rs2165241. The T allele of rs2165241 and the G allele of
rs1048661 are the at-risk alleles in Caucasians, with an OR of
3.39 and 2.35, respectively. In contrast, the two alleles are
protective in the Japanese population, with an OR of 0.13 and
0.03, respectively. All the ORs are statistically significant
with p values <0.00001. Therefore, it is more likely that SNPs
rs1048661 and rs2165241 are not directly implicated in the
pathogenesis of XFS/XFG. In contrast, the distribution of
SNP rs3825942 followed a similar pattern in all three ethnic
groups. The G allele was the at-risk allele, and the OR was
9.30, 18.72, 10.97, and 4.17 in Caucasian, Japanese, Chinese
and Indian populations, respectively. The total OR was 10.75
(95% CI 7.08–16.31). Our finding suggests that rs3825942 is
the  common  disease-associated  polymorphism  across
different populations and may have functional impacts on the
LOXL1 protein and contribute to the pathogenesis of XFS/
XFG. Moreover, in the third part of this meta-analysis, we
found  that  the  OR  for  the  homozygous  genotype  of
rs3825942 is 9.42, while the OR for the heterozygote is not
statistically significant. Moreover, the OR in the recessive
model  was  the  highest  among  different  genetic  models
(OR=14.55). Therefore, it could be inferred that rs3825942
plays a role in a recessive pattern; however, what functional
role  rs3825942  played  in  the  pathogenesis  of  XFS/XFG
remains  unclear.  LOXL1  is  located  in  15q22,  encoding  a
member of the lysyl oxidase family. The LOXL family is an
extracellular copper-dependent amine oxidase that involved
in the first step of the formation of cross-links in collagen and
elastin.  Therefore,  sequence  variation  in  LOXL1  may
influence the function, synthesis, and subsequent deposition
of the extracellular tissues [37]. SNP rs3825942 is located in
the first exon of LOXL1 and leads to a nonsynonymous amino
acid  change  from  glycine  to  asparagine  at  position  153
(G153D).  However,  functional  prediction  using  in  silico
programs  Polymorphism  Phenotyping  (PolyPhen)  and
Sorting Intolerant From Tolerant (SIFT) suggested that the
amino  acid  substitution  is  benign  and  tolerated  (data  not
shown).  The  exact  functional  effects  of  this  substitution
remain to be further investigated.
The  association  of  LOXL1  SNPs  with  other  types  of
glaucoma, including POAG, NTG, pigmentary glaucoma, and
PACG, were reviewed in this meta-analysis. However, no
significant  association  was  found  between  POAG  and
LXOL1  SNPs  after  merging  the  results  from  13  cohorts.
Therefore, it is likely that LOXL1 is not implicated in the
primary open angle glaucomatous mechanism. Associations
between LXOL1 SNPs and NTG, pigmentary glaucoma, or
PACG were also negative, although the number of articles
included  in  this  meta-analysis  was  limited.  The  lack  of
association  between  LOXL1  and  primary  glaucoma  has
provided evidence supporting that LOXL1 is linked to the
pathogenesis of the exfoliation syndrome but not the direct
genetic cause of IOP elevation and subsequent glaucoma.
In  summary,  by  using  meta-analysis  the  genetic
homogeneity of LOXL1 between XFS and XFG has been
confirmed.  The  genetic  effect  of  rs3825942  is  similar  in
different  populations  in  a  recessive  genetic  model.  We
detected  inconsistencies  in  the  effect  of  rs1048661  and
rs2165241 between Caucasian and Japanese populations. Our
results  also  revealed  that  the  LOXL1  gene  is  not  a
Figure  13.  Meta-analysis  of  the  association  of  single  nucleotide
polymorphism (SNP) rs3825942 with primary open angle glaucoma
(POAG). Squares indicate study-specific odds  ratio  (OR); the size
of the box is proportional to the weight of the study; horizontal lines
indicate 95% confidence interval (CI); diamond indicates summary
OR with its corresponding 95% CI. Meta-analysis indicated there is
no statistical significant association of SNP rs3825942 with POAG.
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175susceptibility gene of other types of glaucoma other than
XFG.  Further  genetic  studies  are  required  to  unravel  the
discrepancy  in  LD  patterns  of  the  LOXL1  gene  among
different populations.
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